Literature DB >> 22582037

22q11.2 Distal Deletion Syndrome: Description of a New Case with Truncus Arteriosus Type 2 and Review.

L Garavelli1, S Rosato, A Wischmeijer, C Gelmini, A Esposito, L Mazzanti, F Franchi, A De Crescenzo, O Palumbo, M Carella, A Riccio.   

Abstract

22q11.2 deletion syndrome is mainly characterized by conotruncal congenital heart defects, velopharyngeal insufficiency, hypocalcemia and a characteristic craniofacial appearance. The etiology in the majority of patients is a 3-Mb recurrent deletion in region 22q11.2. Nevertheless, recently some cases of infrequent deletions with various sizes have been reported with a different phenotype. We report on a patient with congenital heart disease (truncus arteriosus type 2) in whom a de novo 1.3-Mb 22q11.2 deletion was detected by array comparative genomic hybridization. The deletion described corresponds to an atypical and distal deletion which spans low copy repeat (LCR) 4 and is associated with breakpoint sites that do not correspond to known LCRs of 22q11.2. We examine the clinical phenotype of our case and compare our findings with those published in the literature. The most prevalent clinical features in this type of deletion are a history of prematurity, pre-natal and post-natal growth retardation, slight facial dysmorphic features, microcephaly and developmental delay, with a speech defect in particular. These are clearly different from those found in the classic 22q11.2 deletion syndrome, and we believe that the main differential diagnosis should be with Silver-Russel syndrome. In our case we observe the cardiac phenotype with truncus arteriosus communis usually seen in the classic 22q11.2 deletion syndrome, and so far associated with the TBX1 gene. Significantly, however, TBX1 is not included in our patient's deletion. The possible roles of a position effect or other genes are discussed.

Entities:  

Year:  2011        PMID: 22582037      PMCID: PMC3343753          DOI: 10.1159/000334262

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  28 in total

1.  A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects.

Authors:  S C Saitta; J M McGrath; H Mensch; T H Shaikh; E H Zackai; B S Emanuel
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 2.  Genome architecture, rearrangements and genomic disorders.

Authors:  Paweł Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2002-02       Impact factor: 11.639

3.  A novel atypical 22q11.2 distal deletion in father and son.

Authors:  S Garcia-Miñaur; J Fantes; R S Murray; M E M Porteous; L Strain; J E Burns; J Stephen; J P Warner
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

4.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.

Authors:  C Carlson; H Sirotkin; R Pandita; R Goldberg; J McKie; R Wadey; S R Patanjali; S M Weissman; K Anyane-Yeboa; D Warburton; P Scambler; R Shprintzen; R Kucherlapati; B E Morrow
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  A novel 22q11.2 microdeletion in DiGeorge syndrome.

Authors:  A Rauch; R A Pfeiffer; G Leipold; H Singer; M Tigges; M Hofbeck
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

6.  Deletion mapping of 22q11 in CATCH22 syndrome: identification of a second critical region.

Authors:  H Kurahashi; T Nakayama; Y Osugi; E Tsuda; M Masuno; K Imaizumi; T Kamiya; T Sano; S Okada; I Nishisho
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

7.  Another critical region for deletion of 22q11: a study of 100 patients.

Authors:  H Kurahashi; E Tsuda; R Kohama; T Nakayama; M Masuno; K Imaizumi; T Kamiya; T Sano; S Okada; I Nishisho
Journal:  Am J Med Genet       Date:  1997-10-17

8.  Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome.

Authors:  D L Guris; J Fantes; D Tara; B J Druker; A Imamoto
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

9.  High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.

Authors:  Eric M Jackson; Tamim H Shaikh; Sridharan Gururangan; Marilyn C Jones; David Malkin; Sarah M Nikkel; Craig W Zuppan; Luanne M Wainwright; Fan Zhang; Jaclyn A Biegel
Journal:  Hum Genet       Date:  2007-05-31       Impact factor: 4.132

10.  Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.

Authors:  Angela Sparago; Silvia Russo; Flavia Cerrato; Serena Ferraiuolo; Pierangela Castorina; Angelo Selicorni; Christine Schwienbacher; Massimo Negrini; Giovanni Battista Ferrero; Margherita Cirillo Silengo; Cecilia Anichini; Lidia Larizza; Andrea Riccio
Journal:  Hum Mol Genet       Date:  2006-12-11       Impact factor: 6.150

View more
  7 in total

1.  Neural tube defects and atypical deletion on 22q11.2.

Authors:  Chiara Leoni; David A Stevenson; Katherine B Geiersbach; Christian N Paxton; Bryan L Krock; Rong Mao; Alan F Rope
Journal:  Am J Med Genet A       Date:  2014-08-13       Impact factor: 2.802

2.  Topoisomerase 3β knockout mice show transcriptional and behavioural impairments associated with neurogenesis and synaptic plasticity.

Authors:  Yuyoung Joo; Yutong Xue; Yue Wang; Ross A McDevitt; Nirnath Sah; Simone Bossi; Shuaikun Su; Seung Kyu Lee; Wei Peng; Aoji Xie; Yongqing Zhang; Yi Ding; Wai Lim Ku; Soumita Ghosh; Kenneth Fishbein; Weiping Shen; Richard Spencer; Kevin Becker; Keji Zhao; Mark P Mattson; Henriette van Praag; Alexei Sharov; Weidong Wang
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

3.  Molecular Etiology Disclosed by Array CGH in Patients With Silver-Russell Syndrome or Similar Phenotypes.

Authors:  Milena Crippa; Maria Teresa Bonati; Luciano Calzari; Chiara Picinelli; Cristina Gervasini; Alessandra Sironi; Ilaria Bestetti; Sara Guzzetti; Simonetta Bellone; Angelo Selicorni; Alessandro Mussa; Andrea Riccio; Giovanni Battista Ferrero; Silvia Russo; Lidia Larizza; Palma Finelli
Journal:  Front Genet       Date:  2019-10-15       Impact factor: 4.599

4.  Topoisomerase IIIβ Deficiency Induces Neuro-Behavioral Changes and Brain Connectivity Alterations in Mice.

Authors:  Faiz Ur Rahman; You-Rim Kim; Eun-Kyeung Kim; Hae-Rim Kim; Sang-Mi Cho; Chin-Soo Lee; Su Jin Kim; Kimi Araki; Ken-Ichi Yamamura; Mi-Ni Lee; Seul Gi Park; Won-Kee Yoon; Kihoon Lee; Young-Suk Won; Hyoung-Chin Kim; Younghee Lee; Ho-Young Lee; Ki-Hoan Nam
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

5.  Genotype-phenotype correlation in 22q11.2 deletion syndrome.

Authors:  Elena Michaelovsky; Amos Frisch; Miri Carmel; Miriam Patya; Omer Zarchi; Tamar Green; Lina Basel-Vanagaite; Abraham Weizman; Doron Gothelf
Journal:  BMC Med Genet       Date:  2012-12-17       Impact factor: 2.103

6.  Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCR.

Authors:  Vicki J Hwang; Dianna Maar; John Regan; Kathleen Angkustsiri; Tony J Simon; Flora Tassone
Journal:  BMC Med Genet       Date:  2014-10-14       Impact factor: 2.103

7.  The Identification of Microdeletion and Reciprocal Microduplication in 22q11.2 Using High-Resolution CMA Technology.

Authors:  Ana Julia Cunha Leite; Irene Plaza Pinto; Damiana Mirian da Cruz E Cunha; Cristiano Luiz Ribeiro; Claudio Carlos da Silva; Aparecido Divino da Cruz; Lysa Bernardes Minasi
Journal:  Biomed Res Int       Date:  2016-03-31       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.